These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25827960)

  • 41. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
    Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
    Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
    Behan LA; Carmody D; Rogers B; Hannon MJ; Davenport C; Tormey W; Smith D; Thompson CJ; Stanton A; Agha A
    Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trial.
    Suh SY; Choi YS; Oh SC; Kim YS; Cho K; Bae WK; Lee JH; Seo AR; Ahn HY
    J Pain Symptom Manage; 2013 Oct; 46(4):474-82. PubMed ID: 23498965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study.
    Barreveld AM; Correll DJ; Liu X; Max B; McGowan JA; Shovel L; Wasan AD; Nedeljkovic SS
    Pain Med; 2013 Jun; 14(6):925-34. PubMed ID: 23786558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment.
    Rhodin A; Stridsberg M; Gordh T
    Clin J Pain; 2010 Jun; 26(5):374-80. PubMed ID: 20473043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial.
    Malafoglia V; Celi M; Muscoli C; Ilari S; Lauro F; Giancotti LA; Morabito C; Feola M; Tarantino U; Raffaeli W
    Trials; 2017 Dec; 18(1):605. PubMed ID: 29258584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot study.
    Webster LR; Smith MD; Mackin S; Iverson M
    Pain Med; 2015 Mar; 16(3):460-71. PubMed ID: 25279807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uncertainties in endocrine substitution therapy for central hypocortisolism.
    Swords FM
    Handb Clin Neurol; 2014; 124():387-96. PubMed ID: 25248601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.
    Breuer B; Pappagallo M; Knotkova H; Guleyupoglu N; Wallenstein S; Portenoy RK
    Clin Ther; 2007 Sep; 29(9):2022-30. PubMed ID: 18035201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary adrenal insufficiency and pituitary dysfunction in oral/transdermal opioid users with non-cancer pain.
    Lamprecht A; Sorbello J; Jang C; Torpy DJ; Inder WJ
    Eur J Endocrinol; 2018 Dec; 179(6):353-362. PubMed ID: 30324794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain.
    Wasan AD; Michna E; Edwards RR; Katz JN; Nedeljkovic SS; Dolman AJ; Janfaza D; Isaac Z; Jamison RN
    Anesthesiology; 2015 Oct; 123(4):861-72. PubMed ID: 26375824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term treatment in chronic noncancer pain: Results of an observational study comparing opioid and nonopioid therapy.
    Elsesser K; Cegla T
    Scand J Pain; 2017 Oct; 17():87-98. PubMed ID: 28850379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.